Clincosm LogoSign in Get a demo

peritoneal cancer

Showing 76 - 100 of 116
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

From Home in Patients Recovering From Major Gynecologic Cancer

Completed
Has Results
  • Fallopian Tube Cancer
  • +5 more
  • online platform WEBCORE
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 13, 2018

Peritoneal Cancer, Ovarian Cancer, Tumors, Ovarian Trial in Australia, Singapore, United States (GW786034)

Completed
Has Results
  • Peritoneal Cancer
  • +3 more
  • Atlanta, Georgia
  • +9 more
Sep 13, 2018

Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Boston (Bevacizumab, Cyclophosphamide)

Completed
Has Results
  • Ovarian Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 10, 2018

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Boston (Sunitinib)

Completed
Has Results
  • Ovarian Cancer
  • +2 more
  • Boston, Massachusetts
  • +2 more
Jul 26, 2018

Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Boston (Carboplatin, Pemetrexed)

Completed
  • Ovarian Cancer
  • +2 more
  • Boston, Massachusetts
  • +2 more
Aug 10, 2018

Ovarian Cancer, Endometrial Cancer, Cervical Cancer Trial in Boston (Docetaxel, PTK787)

Completed
  • Ovarian Cancer
  • +5 more
  • Boston, Massachusetts
  • +1 more
Jul 26, 2018

Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in United States (entinostat, avelumab, Placebo)

Unknown status
  • Epithelial Ovarian Cancer
  • +2 more
  • Tampa, Florida
  • +11 more
Jul 9, 2018

Fallopian Tubes Cancer, Ovarian Cancer, Peritoneal Cancer Trial in New York (bevacizumab and the polyvalent vaccine-KLH

Completed
Has Results
  • Fallopian Tubes Cancer
  • +2 more
  • bevacizumab and the polyvalent vaccine-KLH conjugate + OPT-821
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
May 14, 2018

Ovarian Carcinoma, Fallopian Tube Cancer, Peritoneal Cancer Trial in United States (Alisertib, Paclitaxel)

Completed
Has Results
  • Ovarian Carcinoma
  • +3 more
  • Bronx, New York
  • +3 more
May 1, 2018

Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Farmington (Bevacizumab, Carboplatin, Paclitaxel)

Terminated
Has Results
  • Ovarian Cancer
  • +4 more
  • Farmington, Connecticut
    University of Connecticut Health Center
Feb 6, 2018

Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Greenville (Prolanta, a human prolactin receptor antagonist)

Unknown status
  • Ovarian Cancer
  • +2 more
  • Prolanta, a human prolactin receptor antagonist
  • Greenville, South Carolina
    ITOR/GHS
Feb 13, 2018

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Boston (carboplatin, pralatrexate, Folic Acid)

Completed
Has Results
  • Ovarian Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Dec 20, 2017

Peritoneal Cancer, Ovarian Cancer, Tumors, Ovarian Trial in Canada, United States (Topotecan, Gemcitabine)

Completed
  • Peritoneal Cancer
  • +3 more
  • Los Gatos, California
  • +18 more
Jun 8, 2017

Pathophysiology of Inflammation After Cytoreductive Surgery and

Unknown status
  • Peritoneal Cancer
  • CRS and HIPEC
  • Zurich, Switzerland
    Division of Visceral Surgery and Transplantation , University Ho
May 3, 2017

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Canada, United States (DPX-Survivac, low dose cyclophosphamide

Completed
  • Ovarian Cancer
  • +2 more
  • DPX-Survivac
  • low dose cyclophosphamide (oral)
  • Buffalo, New York
  • +6 more
Apr 20, 2017

Fallopian Tubes, Ovarian Cancer, Peritoneal Cancer Trial in New York (Globo-H-GM2-sTn-TF-Tn-KLH conjugate, plus the

Completed
  • Fallopian Tubes
  • +2 more
  • Globo-H-GM2-sTn-TF-Tn-KLH conjugate, plus the immunological adjuvant QS-21
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 13, 2017

Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cancer Trial in Worldwide (AMG 386, Paclitaxel, AMG 386 Placebo)

Terminated
  • Fallopian Tube Cancer
  • +2 more
  • AMG 386
  • +3 more
  • Birmingham, Alabama
  • +309 more
Feb 22, 2017

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Ann Arbor (Alemtuzumab)

Terminated
  • Ovarian Cancer
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Dec 1, 2016

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Rochester (Alvimopan, Placebo)

Completed
Has Results
  • Ovarian Cancer
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Aug 30, 2016

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in United States (MM-121, Paclitaxel)

Completed
Has Results
  • Epithelial Ovarian Cancer
  • +2 more
  • Glendale, Arizona
  • +9 more
Apr 11, 2016

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Houston (Femara, Placebo)

Withdrawn
  • Ovarian Cancer
  • +2 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Apr 19, 2016

Ovarian Cancer, Peritoneal Cancer, Cancer of the Fallopian Tube Trial (Tamoxifen, Chemotherapy)

Completed
  • Ovarian Cancer
  • +2 more
  • (no location specified)
Apr 4, 2016

Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Leeds (Diagnostic analysis)

Unknown status
  • Epithelial Ovarian Cancer
  • +3 more
  • Diagnostic analysis
  • Leeds, West Yorkshire, United Kingdom
    Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust
Feb 23, 2016

Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in United States (Placebo, Gemcitabine, Pertuzumab)

Completed
Has Results
  • Ovarian Cancer
  • +2 more
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +40 more
Jun 8, 2015

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Seattle (Topotecan, Bevacizumab)

Completed
Has Results
  • Ovarian Cancer
  • +2 more
  • Seattle, Washington
  • +1 more
Apr 29, 2015